Publications by authors named "V A Mazurov"
Article Synopsis
- Netakimab has shown effective results in controlled trials for treating ankylosing spondylitis (AS), and this study investigates its efficacy and safety in everyday clinical settings over a year.
- The observational study included 137 patients from 23 centers in Russia, focusing on retention rates and the impact of netakimab therapy at multiple time points during the year.
- Findings revealed that 90.4% of patients continued treatment after one year, and significant improvements were observed in disease activity scores, with only a small percentage experiencing adverse effects.
Unlabelled: . Previously, 24-week results of phase III double-blind, placebo-controlled randomized clinical study (SOLAR) of levilimab in subjects with active rheumatoid arthritis (RA) proved a superiority of levilimab over placebo. Here, we present 1-year efficacy and safety data of the SOLAR study.
View Article and Find Full Text PDFBackground: Non-pharmacological treatments based on collagen as a dietary supplement are emerging as a new area of interest to support preventive or therapeutic effects in patients with osteoarthritis (OA).
Aim: In a multicenter, prospective, double-blind, placebo-controlled, randomized study, to evaluate the effectiveness and safety of the use of the Artneo complex containing undenatured chicken collagen type II in patients with OA of the knee joints.
Materials And Methods: The study enrolled 212 outpatients from 12 centers in the Russian Federation with knee OA, stages II and III according to the Kellgren-Lawrence classification.
Aim: To evaluate the efficacy of Artneo (AN) in comparison with a combination of glucosamine hydrochloride and chondroitin sulfate (GC) in patients with osteoarthritis (OA) of the knee joint (KJ).
Materials And Methods: 70 patients with stages I-III of primary knee OA were randomized into 2 groups. Participants in the 1st (=35) took AN 1 caps/day, in the 2nd (=35) GC according to the standard regimen.